In Brief: Ephedrine misuse
This article was originally published in The Tan Sheet
Executive Summary
Ephedrine misuse: AMA will "work on a national level to broaden physician awareness about, and support efforts to reduce, the illicit use of ephedrine as a psychostimulant and as a precursor for methcathinone," the association's House of Delegates agreed during their June 18-22 policy-setting conference in Chicago. Delegates expressed concern about continued use of ephedrine to manufacture street drugs despite FDA and DEA efforts to combat this problem , but also cautioned against restrictions that may be so severe as to limit legitimate uses of the product...